Current advances in nanocarriers for biomedical research and their applications
Source abstract
Abstract
Nanodrug delivery systems sometimes referred to as nanocarriers (NCs) are nanoengineered biocompatible materials or devices, which in conjugation with desired bioactive compounds plays an indispensable functional role in the field of pharmaceutical and allied sciences. The diversified ability of this bioengineered colloidal or noncolloidal molecule to breach the biological barriers to reach the targeted location in the biological system uplifts its other versatile natures of mono- or polydispersity in biodistribution. Furthermore, its nontoxicity and biodegradability result in making it a unique candidate for its purpose as drug delivery system. A number of different conjugations of chemical and biological substances are currently implemented for the synthesis of this biofunctional hybrid nanomaterial by simple methods. The use of these bioconjugated as a nanoparticulated system is currently being used for the treatment of various deadly incurable infectious diseases such as tuberculosis and disorders such as diabetes and cancers of various forms. Henceforth, the objective of the present review article is to provide overviews of the diversified and types of nanoparticulated systems, their beneficial as well as deleterious impacts along with the future prospect of nanodrug delivery system based on present status.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
P.G. Department of Biotechnology, Utkal Univesity, Bhubaneswar, India;
Department of Food Science and Biotechnology, Dongguk University, Gyeonggi-do, Republic of Korea;
Amity Institute of Forestry and Wildlife, Amity University, Noida, Uttar Pradesh, India;
Research Institute of Biotechnology & Medical Converged Science, Dongguk University-Seoul, Gyeonggi-do, Republic of Korea;
São Paulo State University (UNESP), Institute of Science and Technology of Sorocaba, Sorocaba, Brazil
References (65)
Show source-provided references
1. Bodaiah B · Int J Recent Sci Res · 2016 · 7 · 10652
2. Cerna T · J Metallomics Nanotechnol · 2016 · 4 · 6
3. Sowjanya KA · Res Rev J Med Health Sci · 2015 · 4 · 1
4. 10.1016/j.jconrel.2016.05.04410.1016/j.jconrel.2016.05.044 ↗
5. 10.1016/j.ijpharm.2016.11.06110.1016/j.ijpharm.2016.11.061 ↗
6. 10.1016/j.jconrel.2016.11.02510.1016/j.jconrel.2016.11.025 ↗
7. 10.3390/ijms1709144010.3390/ijms17091440 ↗
8. 10.1002/wnan.142110.1002/wnan.1421 ↗
9. 10.1016/j.ijpharm.2016.11.06010.1016/j.ijpharm.2016.11.060 ↗
10. 10.1002/btm2.1000310.1002/btm2.10003 ↗
11. Pandey P · J Crit Rev · 2016 · 3 · 18
12. 10.32607/20758251-2014-6-1-35-4410.32607/20758251-2014-6-1-35-44 ↗
13. 10.4103/0975-7406.7212710.4103/0975-7406.72127 ↗
14. 10.1016/j.jare.2015.02.00710.1016/j.jare.2015.02.007 ↗
15. 10.1016/j.saa.2014.05.07610.1016/j.saa.2014.05.076 ↗
16. 10.1016/j.saa.2014.05.07810.1016/j.saa.2014.05.078 ↗
17. 10.4172/2572-0813.100010710.4172/2572-0813.1000107 ↗
18. 10.2174/156802661566615041414475010.2174/1568026615666150414144750 ↗
19. 10.15406/jabb.2017.03.0005910.15406/jabb.2017.03.00059 ↗
20. 10.1016/j.jphotobiol.2016.07.03710.1016/j.jphotobiol.2016.07.037 ↗
21. 10.1021/acs.langmuir.6b0021410.1021/acs.langmuir.6b00214 ↗
22. Maniya NH · Rev Adv Mater Sci · 2016 · 44 · 257
23. 10.1016/j.aquatox.2015.03.01410.1016/j.aquatox.2015.03.014 ↗
24. 10.1016/j.carbon.2016.03.04110.1016/j.carbon.2016.03.041 ↗
25. 10.1016/j.bios.2014.07.04410.1016/j.bios.2014.07.044 ↗
26. 10.1021/nn506782f10.1021/nn506782f ↗
27. 10.1016/j.nano.2015.11.02110.1016/j.nano.2015.11.021 ↗
28. 10.1016/j.colsurfb.2016.08.05210.1016/j.colsurfb.2016.08.052 ↗
29. 10.3390/ijms1707111110.3390/ijms17071111 ↗
30. 10.1016/j.talanta.2009.09.02910.1016/j.talanta.2009.09.029 ↗
31. 10.1007/s10544-015-9952-y10.1007/s10544-015-9952-y ↗
32. Reddy DY · J Med Pharm Innov · 2015 · 2 · 19
33. 10.1080/03602559.2014.95878010.1080/03602559.2014.958780 ↗
34. 10.1016/j.actbio.2017.01.00710.1016/j.actbio.2017.01.007 ↗
35. Senthil KP · Int J Sci Environ Technol · 2016 · 5 · 4447
36. 10.1016/j.addr.2005.09.01810.1016/j.addr.2005.09.018 ↗
37. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
38. Magdum AS · Indo Am J Pharm Sci · 2017 · 8 · 2710
39. Bibhas CM · J Nanosci Curr Res · 2017 · 2 · 112
40. Bose S · IOSR J Pharm Biol Sci · 2015 · 10 · 01
41. 10.3390/jcm509008210.3390/jcm5090082 ↗
42. Jain N · Asian J Pharm Clin Res · 2010 · 3 · 159
43. 10.1016/j.yexmp.2008.12.00410.1016/j.yexmp.2008.12.004 ↗
44. 10.3390/ijms1801012010.3390/ijms18010120 ↗
45. 10.1016/S1734-1140(12)70901-510.1016/S1734-1140(12)70901-5 ↗
46. 10.1002/ajh.2420110.1002/ajh.24201 ↗
47. Wanigasekara J · Curr Trends Biotechnol Pharm · 2016 · 10 · 78
48. 10.19080/GJN.2016.01.55555110.19080/GJN.2016.01.555551 ↗
49. 10.1016/j.addr.2016.04.02510.1016/j.addr.2016.04.025 ↗
50. 10.1016/j.jhazmat.2016.12.04410.1016/j.jhazmat.2016.12.044 ↗
51. 10.1016/j.tox.2017.02.00710.1016/j.tox.2017.02.007 ↗
52. 10.1016/j.aquatox.2016.12.00910.1016/j.aquatox.2016.12.009 ↗
53. 10.1016/j.aquatox.2017.01.00610.1016/j.aquatox.2017.01.006 ↗
54. 10.1016/j.jes.2016.08.01510.1016/j.jes.2016.08.015 ↗
55. 10.3389/fpls.2017.0000110.3389/fpls.2017.00001 ↗
56. 10.1080/01480545.2016.119956310.1080/01480545.2016.1199563 ↗
57. 10.1016/j.ecoenv.2015.09.03010.1016/j.ecoenv.2015.09.030 ↗
58. 10.3109/17435390.2015.110298110.3109/17435390.2015.1102981 ↗
59. 10.1016/j.etap.2016.05.00410.1016/j.etap.2016.05.004 ↗
60. 10.1080/15287394.2016.121959410.1080/15287394.2016.1219594 ↗
61. 10.1080/17435390.2016.123573710.1080/17435390.2016.1235737 ↗
62. 10.1016/j.taap.2015.12.01510.1016/j.taap.2015.12.015 ↗
63. 10.1248/bpb.b16-0026410.1248/bpb.b16-00264 ↗
64. 10.1097/MD.000000000000126610.1097/MD.0000000000001266 ↗
65. 10.1021/acs.chemrev.5b0011610.1021/acs.chemrev.5b00116 ↗